These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 37795578)

  • 1. Roles of long noncoding RNA in triple-negative breast cancer.
    Das PK; Siddika A; Rashel KM; Auwal A; Soha K; Rahman MA; Pillai S; Islam F
    Cancer Med; 2023 Oct; 12(20):20365-20379. PubMed ID: 37795578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.
    Eades G; Wolfson B; Zhang Y; Li Q; Yao Y; Zhou Q
    Mol Cancer Res; 2015 Feb; 13(2):330-8. PubMed ID: 25253741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNAs (lncRNAs) in triple negative breast cancer.
    Wang Q; Gao S; Li H; Lv M; Lu C
    J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis.
    Zhang S; Ma F; Xie X; Shen Y
    Medicine (Baltimore); 2020 Sep; 99(37):e21861. PubMed ID: 32925722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA landscape in triple-negative breast cancer.
    Zhang W; Guan X; Tang J
    Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs: From disease code to drug role.
    Chen Y; Li Z; Chen X; Zhang S
    Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles and expression profiles of long non-coding RNAs in triple-negative breast cancers.
    Kong X; Liu W; Kong Y
    J Cell Mol Med; 2018 Jan; 22(1):390-394. PubMed ID: 28941134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel long non-coding RNAs in triple-negative breast cancer.
    Shen X; Xie B; Ma Z; Yu W; Wang W; Xu D; Yan X; Chen B; Yu L; Li J; Chen X; Ding K; Cao F
    Oncotarget; 2015 Aug; 6(25):21730-9. PubMed ID: 26078338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer: Current Molecular Therapeutic Targets and New Players.
    Nagini S
    Anticancer Agents Med Chem; 2017; 17(2):152-163. PubMed ID: 27137076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Differentially Expressed LncRNAs in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.
    Tuluhong D; Dunzhu W; Wang J; Chen T; Li H; Li Q; Wang S
    Crit Rev Eukaryot Gene Expr; 2020; 30(5):447-456. PubMed ID: 33389881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis.
    Thakur KK; Kumar A; Banik K; Verma E; Khatoon E; Harsha C; Sethi G; Gupta SC; Kunnumakkara AB
    J Cell Physiol; 2021 Dec; 236(12):7938-7965. PubMed ID: 34105151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702.
    Mou E; Wang H
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31399501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted roles of long non-coding RNAs in triple-negative breast cancer: biology and clinical applications.
    Rajagopal T; Talluri S; Venkatabalasubramanian S; Dunna NR
    Biochem Soc Trans; 2020 Dec; 48(6):2791-2810. PubMed ID: 33258920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening protective miRNAs and constructing novel lncRNAs/miRNAs/mRNAs networks and prognostic models for triple-negative breast cancer.
    Zhao Y; Song Y; Zhang Y; Ji M; Hou P; Sui F
    Mol Cell Probes; 2023 Dec; 72():101940. PubMed ID: 37871689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.